01—Abstract
Summary
Summary of the 8-K filed August 11, 2026. Cited figures are marked; the original filing is the authoritative source.
CME Group Inc. (CME) filed a Form 8-K on August 11, 2026, primarily to disclose a change in its pricing structure communicated to clients through Special Executive Report No. 9799.
While the specifics of the pricing adjustments are not detailed in this 8-K, the filing indicates that this information has been made available to clients and posted on the company's website. Investors should note that this filing is made under Regulation FD and is for disclosure purposes, not to trigger specific financial reporting requirements. The information provided is not deemed "filed" under the Securities Exchange Act of 1934, meaning it doesn't carry the same legal implications as other types of filings, and will not be incorporated by reference into other SEC filings unless explicitly stated.
02—Key points
Key Highlights
- CME Group Inc. announced pricing changes to its clients on August 11, 2026.
- The pricing adjustments were communicated via a Special Executive Report No. 9799.
- Details of the pricing changes are available to clients and have been posted on the CME Group website.
- The filing is made under Regulation FD, ensuring broad public disclosure.
- The information furnished is not considered 'filed' for purposes of Section 18 of the Exchange Act, limiting its liability implications.
- This filing does not alter CME Group's financial statements or existing exhibits, with the exception of the XBRL cover page.
03—Questions
Frequently Asked Questions
What is the main purpose of this 8-K filing?
The main purpose of this 8-K filing is to publicly disclose that CME Group Inc. has communicated changes to its client pricing structure. This is done under Regulation FD to ensure all stakeholders are informed simultaneously.
Where can I find the details of the pricing changes?
According to the filing, details of the pricing changes were communicated to clients via Special Executive Report No. 9799 and have been posted on CME Group's website. Investors should refer to these sources for specific information.
Does this filing change CME Group's financial reporting?
No, this filing is primarily a disclosure under Regulation FD and does not present new financial statements or significantly alter the company's financial reporting. The information furnished is not deemed 'filed' under the Exchange Act, and therefore, does not change the legal standing of previous filings unless explicitly incorporated by reference.
What are the implications of the information not being 'filed' under Section 18?
Information that is furnished under Item 7.01 and not deemed 'filed' under Section 18 of the Exchange Act means that CME Group Inc. is not subject to the same liabilities related to misstatements or omissions in that specific information as it would be for formally filed information. It serves as a communication tool rather than a formal financial update.
04—Continue